The source of respiratory syncytial virus infection in infants: a household cohort study in rural Kenya

Patrick K Munywoki, Dorothy C Koech, Charles N Agoti, Clement Lewa, Patricia A Cane, Graham F Medley, D J Nokes, Patrick K Munywoki, Dorothy C Koech, Charles N Agoti, Clement Lewa, Patricia A Cane, Graham F Medley, D J Nokes

Abstract

Background: Respiratory syncytial virus (RSV) vaccine development for direct protection of young infants faces substantial obstacles. Assessing the potential of indirect protection using different strategies, such as targeting older children or mothers, requires knowledge of the source of infection to the infants.

Methods: We undertook a prospective study in rural Kenya. Households with a child born after the preceding RSV epidemic and ≥ 1 elder sibling were recruited. Nasopharyngeal swab samples were collected every 3-4 days irrespective of symptoms from all household members throughout the RSV season of 2009-2010 and tested for RSV using molecular techniques.

Results: From 451 participants in 44 households a total of 15 396 nasopharyngeal swab samples were samples were collected, representing 86% of planned sampling. RSV was detected in 37 households (84%) and 173 participants (38%) and 28 study infants (64%). The infants acquired infection from within (15 infants; 54%) or outside (9 infants; 32%) the household; in 4 households the source of infant infection was inconclusive. Older children were index case patients for 11 (73%) of the within-household infant infections, and 10 of these 11 children were attending school.

Conclusion: We demonstrate that school-going siblings frequently introduce RSV into households, leading to infection in infants.

Keywords: RSV; households; infants; siblings; transmission.

Figures

Figure 1.
Figure 1.
Number of households participating and individual episodes of respiratory syncytial virus (RSV) A and B infection detected during the follow-up period (weekly delimited data) in 2009–2010.
Figure 2.
Figure 2.
Distribution of primary cases for the 28 household episodes linked with the study infant infection in rural Kenya. Only the first household episodes/outbreaks involving the study infants are shown. The diagonal and zigzag lines shading the circles indicate outside- and within-household acquisition of the infant infections, respectively, and the area of the circle is in proportion to the number of cases in each category.
Figure 3.
Figure 3.
A, Temporal occurrence of respiratory syncytial virus (RSV)–positive samples in a household of 5 members (household 40). Each box represent a sample collected; each circle, an RSV-positive sample. RSV was introduced by subject 4004. B, An Maximum Likelihood phylogenetic tree of 10 of 12 samples from household 40 together with 10 RSV A reference sequences from Kilifi District Hospital (KDH). All samples from household 40 (preceded by triangles on tree) had identical sequences in the G region sequenced. C, Phylogenetic relationship of the G similarity of study infant–primary case pairs for RSV A. Samples from the same household are preceded by the same symbol (filled or open). Taxon naming for the household samples follows household number with individual number and date of sampling (eg, 4703_02April2010 represents household 47, individual 3, and sample collected on 2 April 2010). The KDH RSV A reference sequences are as in B. D, Same as C, but for RSV B. An example RSV B pairing is 3803_14Feb2010 and the later infant-infecting virus sequence 3801_27Feb2010. Ten random samples from the KDH inpatient studies are included for reference, as in B and C.

References

    1. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545–55.
    1. White LJ, Mandl JN, Gomes MG, et al. Understanding the transmission dynamics of respiratory syncytial virus using multiple time series and nested models. Math Biosci. 2007;209:222–39.
    1. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140:543–6.
    1. Ohuma EO, Okiro EA, Ochola R, et al. The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease. Am J Epidemiol. 2012;176:794–802.
    1. Machata AM, Kabon B, Willschke H, Prayer D, Marhofer P. Upper airway size and configuration during propofol-based sedation for magnetic resonance imaging: an analysis of 138 infants and children. Paediatr Anaesth. 2010;20:994–1000.
    1. Karron RA, Wright PF, Belshe RB, et al. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis. 2005;191:1093–104.
    1. Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine. 2013;31(Suppl 2):B209–15.
    1. Nokes JD, Cane PA. New strategies for control of respiratory syncytial virus infection. Curr Opin Infect Dis. 2008;21:639–43.
    1. Wright PF, Karron RA, Belshe RB, et al. The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. Vaccine. 2007;25:7372–8.
    1. Gonzalez IM, Karron RA, Eichelberger M, et al. Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults. Vaccine. 2000;18:1763–72.
    1. Paradiso PR, Hildreth SW, Hogerman DA, et al. Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old. Pediatr Infect Dis J. 1994;13:792–8.
    1. Langley JM, Sales V, McGeer A, et al. A dose-ranging study of a subunit respiratory syncytial virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age. Vaccine. 2009;27:5913–9.
    1. Englund J, Glezen WP, Piedra PA. Maternal immunization against viral disease. Vaccine. 1998;16:1456–63.
    1. Power UF, Nguyen TN, Rietveld E, et al. Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults. J Infect Dis. 2001;184:1456–60.
    1. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588–98.
    1. Nokes DJ, Ngama M, Bett A, et al. Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance. Clin Infect Dis. 2009;49:1341–9.
    1. Nokes DJ, Okiro EA, Ngama M, et al. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis. 2008;46:50–7.
    1. Scott JA, Bauni E, Moisi JC, et al. Profile: the Kilifi Health and Demographic Surveillance System (KHDSS) Int J Epidemiol. 2012;41:650–7.
    1. Munywoki PK, Hamid F, Mutunga M, Welch S, Cane P, Nokes DJ. Improved detection of respiratory viruses in pediatric outpatients with acute respiratory illness by real-time PCR using nasopharyngeal flocked swabs. J Clin Microbiol. 2011;49:3365–7.
    1. Chan KH, Peiris JS, Lim W, Nicholls JM, Chiu SS. Comparison of nasopharyngeal flocked swabs and aspirates for rapid diagnosis of respiratory viruses in children. J Clin Virol. 2008;42:65–9.
    1. Gunson RN, Collins TC, Carman WF. Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactions. J Clin Virol. 2005;33:341–4.
    1. Agoti CN, Mwihuri AG, Sande CJ, et al. Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya. J Infect Dis. 2012;206:1532–41.
    1. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol. 2011;28:2731–9.
    1. Hall CB, Geiman JM, Biggar R, Kotok DI, Hogan PM, Douglas GR., Jr Respiratory syncytial virus infections within families. N Engl J Med. 1976;294:414–9.
    1. Okiro EA. Transmission dynamics of respiratory syncytial virus within the household and in the community. Kilifi, Kenya: KEMRI-Wellcome Trust Research Programme; 2007. Vol. Doctor of Philosophy: University of Warwick.
    1. Fox JP, Cooney MK, Hall CE. The Seattle virus watch. V. Epidemiologic observations of rhinovirus infections, 1965–1969, in families with young children. Am J Epidemiol. 1975;101:122–43.
    1. Crowcroft NS, Zambon M, Harrison TG, Mok Q, Heath P, Miller E. Respiratory syncytial virus infection in infants admitted to paediatric intensive care units in London, and in their families. Eur J Pediatr. 2008;167:395–9.
    1. Berglund B. Respiratory syncytial virus infections in families. A study of family members of children hospitalized for acute respiratory disease. Acta Paediatr Scand. 1967;56:395–404.
    1. Badger GF, Dingle JH, Feller AE, Hodges RG, Jordan WS, Jr, Rammelkamp CH., Jr A study of illness in a group of Cleveland families. III. Introduction of respiratory infections into families. Am J Hyg. 1953;58:41–6.
    1. Stensballe L, Poulsen A, Nante E, et al. Mothers may transmit RSV infection more easily or severely to sons than daughters: community study from Guinea-Bissau. Scand J Infect Dis. 2004;36:291–5.
    1. Falsey AR, Formica MA, Treanor JJ, Walsh EE. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J Clin Microbiol. 2003;41:4160–5.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa